semaglutide canada patent Off-patent in 2026: the next revolution in anti-obesity medications The story of how Novo

Zydus' semaglutide injection on average costs 2,200 for a month

First-time prescribing of ADMs decreased slightly in March 2025 relative to December (-6.56%), while first-time prescribing of AOMs increased from December 2024 to January 2025, before remaining relatively stable until March 2025 (+18.63%)

10.1093/jexbot/53.372.1305 122 ShimaokaT.YokotaA.MiyakeC

In HIV-related research, daily tesamorelin reduced deep belly fat meaningfully versus placebo, but it works best for body composition, not big weight loss numbers

Head-to-head data published in 2024 have not shown significant differences in serious adverse events 6